Tech Company Financing Transactions

Calixa Therapeutics Funding Round

Canaan Partners, Domain Associates and Frazier Healthcare Partners participated in a $15.1 million funding round for Calixa Therapeutics. The financing round closed on 12/31/2008.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

12481 High Bluff Dr. 150
San Diego, CA 92130
USA

Phone

(858) 480-2420

Website

www.calixainc.com

Email Address

[email protected]

Overview

Calixa Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of a novel cephalosporin to address the expanding problem of multi-drug resistant organisms.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dennis Podlesak

        

Chief Medical Officer

Ian Friedland

        

Executive Vice President

James Ge

        

Vice President

Vernon Jiang

        

Browse more venture capital transactions:

Prev: 12/31/2008: SynergEyes venture capital transaction
Next: 12/31/2008: Biofisica venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary